FeesSafety
Pluang+

Stablecoin market cap steady despite shifts on Ethereum, Tron, and HyperEVM networks

Market News
10 Nov 2026, 14:42 WIB
Tokenpost
View Source
Neutral
Stablecoin market cap steady despite shifts on Ethereum, Tron, and HyperEVM networks

Over the past year, the overall stablecoin market capitalization remained roughly unchanged, even though individual networks saw contrasting trends. Ethereum's stablecoin market cap dropped by $30.6 billion, while Tron and HyperEVM networks experienced increases of $16.1 billion and $6.3 billion respectively. These network-level changes highlight shifting preferences or activity across blockchain platforms but do not explain the underlying causes. The stable total market cap suggests a redistribution rather than growth or decline in stablecoin value overall.

Ethereum stablecoin market cap changes provide context for readers. For those tracking cryptocurrency markets, here is Pluang's snapshot as of Nov 10, 2026 19:44 WIB: Among 50 major cryptocurrencies priced on Pluang, 30 rose and 19 fell today. Notable movers include CRV at Rp4.683 with a 1-day change of -2.88% and a typical hold time of 63 days, BAT at Rp2.338 up 2.35% with 94 days hold time, and FIL at Rp14.048 up 2.29% with 101 days hold time. Pluang order activity shows CRV with 44% sell and 56% buy, while BAT and FIL have 1% sell and 99% buy activity respectively.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
1 hour ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
1 hour ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
1 hour ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
1 hour ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App